revealed that the majority of changes occurred between Days 10 and 12 of SEP. To compare transcript levels between CG-rescued and regressing CL, previously banked rhesus GeneChip array data (NCBI GEO Series GSE10367) from CL collected during the mid-to late and very late luteal phase were analyzed with time-matched intervals in SEP. Comparing RMA-normalized transcripts from the natural cycle (Group 1, CL days 10, 12, (14) (15) (16) (18) (19) with those from luteal rescue (Group 2, hCG-treated samples) revealed 7677 transcripts changing in expression pattern .2-fold (one-way ANOVA, FDR correction; P,0.05) between the two groups. Clustering of samples revealed that the SEP samples possessed the most related transcript expression profiles. Regressed CL (days 18-19, around menses) were the most unlike all other CL. KEGG analysis indicated the most affected pathway was Steroid Biosynthesis; an acute stimulatory response to hCG during SEP was observed for HSD3beta2 and CYP19 mRNA, whereas a chronic stimulatory response occurred for StAR, CYP11A1, CYP17A1, and LHCGR mRNA as measured by real-time PCR. Acute stimulation by CG was noted for PGR, and GCRa mRNA, while acute inhibition by CG was measured for VEGF, CRHBP and 11bHSD2 mRNA. Chronic stimulation was detected for RLN1, CAT, and PGRMC1 mRNA; while message for 11bHSD1 was chronically inhibited during SEP. Transcript levels for the prostaglandin F2a receptor PTGFR, which are up-regulated during luteolysis, were mostly down-regulated by SEP treatment. The most significantly absent pathway (negative z-score) following SEP treatment includes a group of genes whose products promote cell-death. By further comparing the genome-wide changes in luteal gene expression during rescue in SEP, with those in CL during luteolysis in the natural menstrual cycle, it is possible to identify key regulatory pathways promoting fertility. R01 HD20869, RR00163, T32-HD07133 (CVB), China Scholarship Council (CSC; LX). The expression of genes necessary for reverse cholesterol transport (RCT) and cholesterol metabolism is controlled by the liver x receptors (LXR) alpha and beta, members of the nuclear hormone receptor superfamily. Previously, we reported an acute induction of RCT component expression occurs (mRNA and protein) coinciding with the fall in progesterone (P4) synthesis at the end of the luteal phase (i.e., functional regression) in the rhesus macaque corpus luteum (CL). Additionally, we identified three endogenous LXR ligands (22R-hydroxycholesterol and 27-hydroxycholesterol, or 22ROH and 27OH, respectively; and desmosterol) that are present in the CL during the luteal phase. Therefore, LXR regulation of gene expression may be a key determinant of functional regression in the primate CL. To test this hypothesis, we used dispersed primate luteal cell cultures obtained from midluteal stage CL (days 7-8 post LH-surge, peak P4 production) to determine whether synthetic and endogenous LXR ligands: 1) increase expression of known LXR target genes, 2) inhibit expression of cholesterol uptake and steroidogenic genes, and 3) increase cholesterol efflux. The well characterized synthetic LXR agonist T0901317 (T09, 1 lM) as well as the endogenous ligands 22ROH, 27OH, and desmosterol (1 or 5 lM, physiologic range) were incubated with luteal cells for 24 hr. To facilitate uptake of sterols, 0.5% (w:v) beta-cyclodextrin (beta-CDX) was added to the culture media. T09 caused significant (p,0.05) increases compared to vehicle in mRNA levels of known LXR target genes including the cholesterol efflux proteins ATP binding cassette subfamily A1 (ABCA1), and G1 (ABCG1), as well as LXRalpha itself (n = 8). T09 also caused a significant decrease in 3beta-hydroxysteroid dehydrogenase (HSD3B2) mRNA compared to vehicle (p,0.05), but had no effect on low and high density lipoprotein receptors, or steroidogenic acute regulatory protein expression. Surprisingly, beta-CDX itself caused a significant (p,0.05) decrease in ABCA1, ABCG1, and LXRalpha expression in vehicle-treated cells. As beta-CDX is known to deplete cells of sterols, this indicates that there is a high degree of basal LXR gene expression controlled by endogenous sterols. LXR target gene responsiveness to the endogenous ligands varied between luteal preparations. When replicates were divided based on initial LXRalpha mRNA levels (as an indicator of endogenous LXR activity), the 4 cultures with the lowest basal LXRalpha expression had significant (p, 0.05) increases in ABCA1 and/or ABCG1 mRNA levels in response to endogenous ligand (5 lM) treatment. The cultures with the highest LXRalpha levels did not respond to endogenous ligands with statistically significant increases in LXR target gene expression, indicating that luteal cells with higher LXR levels may be refractory to further stimulation. Cholesterol efflux assays were used as a functional endpoint of LXR activation. T09 and the 5 lM doses of 22ROH, 27OH and desmosterol significantly (p,0.05, n = 5) increased cholesterol efflux compared to controls. Collectively, these data indicate that: 1) activation of LXR-mediated RCT may inhibit luteal steroidogenesis by increasing cholesterol efflux and decreasing HSD3B2 expression ultimately causing functional regression, and 2) there is a high degree of basal LXR activity in the primate CL that may need to be repressed during the luteal phase to maintain P4 synthesis. This research was supported by NICHD R01-HD42000 and NCRR RR00163.
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Factor(s) Secreted from Bovine Luteal Cells Alter Function of
Bovine T Lymphocytes. Koji Toyokawa and J.L. Pate. Pennsylvania State University, State College, PA, USA
The overall goal of this research is to understand the function of the bovine corpus luteum (CL), ultimately leading to improved reproductive efficiency in the dairy industry. The specific research focus is to understand how T lymphocytes (T cells) in the bovine CL are regulated during the estrous cycle. We hypothesized that T cell function could be modified not only by cell-cell contact but also via secreted factor(s) from the CL. There are two major protein secretory pathways, termed conventional and unconventional secretory pathways. Most secreted proteins transit through the ER-Golgi system (conventional secretion), whereas some secreted proteins bypass the traditional secretory pathway (unconventional), and the latter secretory pathways are not inhibited by brefeldin A (BFA). In order to test our hypothesis, we utilized BFA to block secretion of conventionally secreted proteins, which also results in upregulation of proteins secreted by unconventional pathways. In this study, conditioned media from luteal cells alone (LC) and from luteal cells treated with BFA (LC+BFA) were utilized to understand autocrine and/or paracrine interactions between T cells and luteal cells. The primary objectives of this study were to determine T cell responses and cytokine production stimulated by factor(s) secreted from luteal cells. First, the efficacy of BFA in altering protein secretion by luteal cells was examined. Secretion of IL-4, one of the conventionally secreted cytokines, was significantly inhibited in LC+BFA compared to conditioned medium from LC (50% reduction, P,0.01). Secondly, we determined if conditioned medium from luteal cells would mediate T cell responses, and further examined if BFArestricted secretion would alter function of T cells. Conditioned media from LC and LC+BFA significantly stimulated T cell proliferation compared to media alone with or without BFA (P,0.01). In addition, LC+BFA-conditioned medium stimulated even higher T cell proliferation than LC-conditioned medium alone (30% and 20%, respectively, P,0.01). However, addition of PGF2a to the culture medium had no additive or synergistic effect on T cell responses. Finally, we investigated if factor(s) secreted from LC-and LC+BFA-conditioned media altered cytokine expression in T cells. Gene expression of IL2, IL2R, IFNc and TGFb was examined in T cells cultured in LC-or LC+BFA-conditioned medium. Unexpectedly, expression of IL2 was significantly downregulated in T cells cultured in LC-and LC+BFA-conditioned media compared to medium alone (P,0.01), whereas expression of IL2R and IFNc in T cells was not changed. However, expression of TGFb (anti-inflammatory cytokine) in T cells was also downregulated in LC-and LC+BFA-conditioned media (P=0.05 and 0.08, respectively). In conclusion, this study provides evidence that autocrine and/or paracrine factor(s) are involved in activation of T cells by luteal cells. Furthermore, it is speculated that different factor(s) may be secreted from luteal cells via unconventional secretions, and factor(s) secreted from luteal cells stimulated by BFA may have more potent stimulatory effects on T cell proliferation. However, the exact molecular mechanisms and identification of luteal-derived factors to modulate T cell functions remain unknown. Olfactomedins are secretary glycoprotein constituted in the extracellular matrix (ECM) of various cell types. Recent studies suggested that Olfm-1 is down-regulated during the window of implantation (WOI) in the human endometrium and upregulated in pathological condition like endometriosis and recurrent spontaneous abortions. Ectopic pregnancy is a gynaecological emergency and fertility threatening phenomenon which occurs in 1-2% of normal pregnancies and shows an increasing trend. Yet, tubal ectopic pregnancy accounts for more than 98% of the cases and the distal part of the fallopian tube accounts for 85-95% of all tubal pregnancies. Our unpublished data demonstrated that the expressions of Olfms are steroid hormonedependent and Olfm-1 affects spheroid attachment onto endometrial epithelial cells in vitro. In the present study, we investigated the spatiotemporal expression of Olfm-1 protein and the transcript of different isoforms (Olfm-1, -2, -3, and -4) in normal Fallopian tubes and tubes with ectopic pregnancies from human samples. Furthermore, an in-vitro-trophoblastic-spheroids and Fallopian-tube-epithelial-cells co-culture model was developed to investigate the possible role of Olfm-1 in tubal ectopic pregnancies using a human Fallopian tube epithelium cell line (OE-E6/E7) and recombinant Olfm-1 protein. Olfm-1 mRNA in the ampullary region showed a significantly lower level (p,0.05) at luteal phase (n=12) than the follicular phase (n=15); whereas there was no significant difference in the infundibullary or isthmic regions between the two phases.The Olfm-1 protein was strongly expressed in the epithelium of the three regions in the human Fallopian tube. The expression of Olfm-1 protein in the infundibulary region is significantly higher (p,0.05) than in the isthmic and ampullary regions in both the follicular (H-SCORE=3.660.3 vs 2.560.3 vs 2.360.7, respectively, n=8) and luteal (H-SCORE=3.560.2 vs 2.460.5 vs 2.360.6, respectively, n=10) phases of the cycle. Interestingly, the ampullary tubal ectopic sections (n=10) showed a significantly lower level of Olfm-1 expression in the epithelium (H-SCORE=1.360.2 when compared to normal ampullae (p,0.05). A trophoblastic-spheroids (JAr) and human-Fallopian-tube-epithelial-cell (OE-E6/E7) co-culture system was established. Treatment of OE-E6/E7 with recombinant human Olfm-1 for 24 hrs dose-dependently (0.01-1lg/ml) reduced JAr spheroids attachment to the OE-E6/E7 monolayers when compared to the untreated controls. Furthermore, activation of the Wnt-signalling pathway using Wnt3a or LiCl was associated with reduced Olfm-1 expression in OE-E6/E7 and increased spheroids attachment to OE-E6/E7 cells, suggesting a possible interaction of Olfm-1 with the Wnt-signalling pathway in the tubal ectopic pregnancy. In sum, Olfm-1 in the human Fallopian tube may function to reduce tubal ectopic embryo attachment. Activation of the Wnt-signaling pathway and down-regulation of Olfm-1 expression favour the spheroid/ embryo attachment onto human WNT genes encode secreted glycoproteins that control cell fate, mortality, proliferation, differentiation, and tissue growth, and subsets (Wnt4, Wnt5a, and Wnt7a) are involved in Mullerian duct patterning and differentiation during embryonic development of the female reproductive tract. The present study investigated potential role of Wnts during postnatal mouse uterine development, because disruption of endometrial adenogenesis and mesenchymal specification and differentiation can cause permanent fertility problems in the adult. The expression of 19 Wnt genes and 10 Fzd receptors was determined by RT-PCR. The spatial expression patterns of the most highly expressed genes: Wn4, Wnt5a, Wnt7a, Wnt7b, Wnt11, Wnt16, Fzd6 and Fzd10 were further examined by in situ hybridization in the neonatal mouse uterus. Wnt4, Wnt5a and Wnt16 were localized in the endometrial stroma, whereas Wnt7a, Wnt7b and Wnt11 were in the uterine epithelia of neonatal mice. Exposure of mice to estrogen or progesterone during critical development periods inhibits endometrial adenogenesis. Diethylstilbestrol (DES) or progesteroneinduced disruption of endometrial gland development was associated with reduction or ablation of Wn4, Wnt5a, Wnt7a, Wnt11, Wnt16 and Fzd10 mRNA during endometrial morphogenesis. Next, we have characterized postnatal uterine morphogenesis by conditionally ablating the expression of Wnt11 in the uterine epithelium of mouse after birth using progesterone receptor (PR) Cre knockin mouse. To increase the efficiency in the production of homozygous null alleles and to decrease the incidence of mosaic deletion, PRcre/+ Wnt11f/-mice were crossed with PRcre/+Wnt11+/-mice to PR+/+Wnt11f/f mice. Wnt11d/d mice did not show disrupted endometrial gland development, and adult Wnt11d/d mice had normal estrus cycles and were fertile. However, we observed disorganized luminal epithelium on postnatal (P) day 7 in Wnt11d/d mice, and levels of Wnt4, Wnt5a, Wnt7a, Wnt7b and Wnt16 in neonatal uteri were decreased in Wnt11d/d mice compared to those in Wnt11f/f mice. Interestingly, ablation of Wnt11 appears to increase the numbers of endometrial glands on P21 and P28. Wnt7a was stimulated on P14 and P21 in uteri of Wnt11f/f mice, whereas Wnt5a and Wnt16 were suppressed by loss of Wnt11. These results implicate that temporal and spatial expression of Wnts are critical factors for endometrial adenogenesis via autocrine and paracrine effects on neonatal uterine development. Further, Wnt11 actions may involve changes in the expression of other members of the Wnt system to regulate uterine morphogenesis. Supported by NIH HD058222.
Steroidal Regulation of Uterine Macrophage Migration Inhibitory
Factor Expression Is Mediated via miRNA-451. Warren B. Nothnick and Caitlin Healy. University of Kansas Medical Center, Kansas City, KS, USA Macrophage migration inhibitory factor (MIF) is a multifunctional cytokine which regulates cell proliferation, angiogenesis and immune cell trafficking. Within the uterus, MIF is expressed primarily by uterine epithelial cells in a cycle stagedependent fashion. Despite characterization of the pattern of uterine MIF expression in a variety of species, virtually no information exists on MIF regulation. As such, the objective of this study was to examine steroidal regulation of Mif in the mouse uterus. Two-month-old, ovariectomized female mice (N=6/treatment group/time point) were treated with estrogen (E2; 1 lg/kg BW) or E2 + progesterone (P4; 2 mg/kg BW) then sacrificed at 0, 4, 8, and 24h post steroid treatment. Uterine Mif was examined by qRT-PCR, Western blot analysis, and immunohistochemical localization. E2 alone, or plus P4, significantly (P,0.05) increased Mif mRNA expression at all time points. Assessment of Mif protein revealed that in contrast to the effect on transcript expression, E2 significantly decreased Mif protein expression by approximately 35% and 65% at 4h and 8h post steroid treatment, respectively, while at 24h, Mif protein levels were approximately 20% below 0h values. Mif localized primarily to luminal and glandular epithelial cells with low stromal expression. The discordant pattern of expression between transcript and protein suggested to us that uterine Mif expression may be regulated by microRNAs (miRs). miR451 is a putative regulator of MIF expression which we have shown to be regulated by E2 within the uterus in a pattern that is inversely correlated to the pattern of Mif uterine protein expression. To test the hypothesis that miR451 regulates Mif protein expression, we transfected human endometrial epithelial cells (HES), with pre-miR-451 precursor, non-targeting precursor (pre-miR-NT; negative control) or transfection buffer alone and assessed miR451 transcript expression by qPCR while MIF protein expression was assessed by Western analysis. Transfection with pre-miR-451 precursor resulted in a significant increase in HES cell expression of mature miR451 which was associated with a significant reduction in MIF protein expression. To further verify that miR451 targets the MIF 3'UTR, HES cells were co-transfected with a Renilla-MIF 3'UTR vector containing the wild-type miR451 seed sequence or a Renilla-MIF 3'UTR mutant vector (mutant miR451 seed sequence), a control vector containing firefly luciferase, and either pre-miR-451 or pre-miR-NT precursors. HES cells cotransfected with constructs which contained the wild-type 3'UTR and pre-miR-451 exhibited significantly less luciferase activity (Renilla normalized to firefly) compared to cells co-transfected with the mutant 3'UTR and pre-miR-451. Cells co-transfected with the mutant 3'UTR and either the pre-miR-451 or pre-miR-NT precursors did not exhibit a significant change in luciferase activity compared to controls. Collectively, these data are interpreted to suggest that miR451 is capable of binding to the 3'UTR of MIF in vitro and suppressing luciferase reporter activity. These observations, coupled with the MIF Western blot data strongly suggest that MIF expression is regulated by miR451. In summary, we demonstrate for the first time that E2 regulates uterine Mif expression and that this regulation appears to be mediated in part by miR451.
